Publications To Date


    Filter Publications

    PAGE 5 OF 78 | DISPLAYING 61 - 75 OF 1166 RESULTS

    Bhatia S et al., Intratumoral delivery of plasmid interleukin-12 via electroporation leads to regression of injected and non-injected tumors in Merkel cell carcinoma, , Clin Cancer Res, Oct 03, 2019

    Delmonico L et al., A Novel Panel of 80 RNA Biomarkers with Differential Expression in Multiple Human Solid Tumors against Healthy Blood Samples., , Int J Mol Sci, Oct 02, 2019

    Kim RD et al., First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma, , Cancer Discovery, Oct 01, 2019

    Annels NE et al., Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer, , Clin Cancer Res, Oct 01, 2019

    Lee J et al., Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial, , Cancer Discovery, Oct 01, 2019

    Renner K et al., Restricting Glycolysis Preserves T Cell Effector Functions and Augments Checkpoint Therapy., , Cell Rep, Oct 01, 2019

    Aushev V et al., Tumor expression of environmental chemical-responsive genes and breast cancer mortality., , Endocr Relat Cancer, Oct 01, 2019

    Kaur G et al., Minichromosome Maintenance Complex (MCM) Genes Profiling and MCM2 Protein Expression in Cervical Cancer Development., , Asian Pac J Cancer Prev, Oct 01, 2019

    Lee O et al., Selective Progesterone Receptor Modulators in Early-Stage Breast Cancer: A Randomized, Placebo-Controlled Phase II Window-of-Opportunity Trial Using Telapristone Acetate., , Clin Cancer Res, Sep 30, 2019

    López‐Sánchez LM et al., SWATH‐based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours., , J Cell Mol Med, Sep 27, 2019

    Guerreiro Stucklin AS et al., Alterations in ALK/ROS1/NTRK/MET drive a group of infantile hemispheric gliomas., , Nat Commun, Sep 25, 2019

    Nixon MJ et al., PIK3CA and MAP3K1 alterations imply luminal A status and are associated with clinical benefit from pan-PI3K inhibitor buparlisib and letrozole in ER+ metastatic breast cancer., , NPJ Breast Cancer, Sep 23, 2019

    Leal FM et al., Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors, , Clin Cancer Res, Sep 23, 2019

    Caetano MS et al., Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses., , Clin Cancer Res, Sep 20, 2019

    Robinson MH et al., Upregulation of the chromatin remodeler HELLS is mediated by YAP1 in Sonic Hedgehog Medulloblastoma., , Sci Rep, Sep 20, 2019